Pharmacokinetics and Safety of Amenamevir in Healthy Subjects: Analysis of Four Randomized Phase 1 Studies

INTRODUCTION: Amenamevir (ASP2151) is a nonnucleoside antiherpesvirus compound available for the treatment of varicella–zoster virus infections. In this article we summarize the findings of four phase 1 studies in healthy participants. METHODS: Four randomized phase 1 studies investigated the safety...

Descripción completa

Detalles Bibliográficos
Autores principales: Kusawake, Tomohiro, Keirns, James J., Kowalski, Donna, den Adel, Martin, Groenendaal-van de Meent, Dorien, Takada, Akitsugu, Ohtsu, Yoshiaki, Katashima, Masataka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5709458/
https://www.ncbi.nlm.nih.gov/pubmed/29134426
http://dx.doi.org/10.1007/s12325-017-0642-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5709458/
https://www.ncbi.nlm.nih.gov/pubmed/29134426
http://dx.doi.org/10.1007/s12325-017-0642-4

Ejemplares similares